Fig. 12
From: Recent developments in epigenetic cancer therapeutics: clinical advancement and emerging trends

Design of dual HDAC-DNMT inhibitor
From: Recent developments in epigenetic cancer therapeutics: clinical advancement and emerging trends

Design of dual HDAC-DNMT inhibitor